Skip to main content

Table 2 Demographic and clinical data for Chinese patients with active or stable SLE

From: Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus

  Active SLE Stable SLE
N 21 25
Age, yr 33.5 ± 14.2** 36.2 ± 12.3
Female, n (%) 19 (90.5)** 23 (92.0)
Male, n (%) 2 (9.5)** 2 (8.0)
ANA (+), n (%) 21 (100) 25 (100)
dsDNA (+), n (%) 14(67)* 6(24)
C3, g/L 0.64 ± 0.41* 0.94 ± 0.35
C4, g/L 0.13 ± 0.11** 0.20 ± 0.13
SLEDAI score 13.9 ± 3.2* 5.4 ± 2.1
  1. Values shown are mean ± SD unless otherwise noted
  2. ANA, anti-nuclear antibody; C, complement; SLEDAI, systemic lupus erythematosus disease activity index
  3. *p < 0.05 compared to stable SLE group
  4. **p > 0.05 compared to stable SLE group